https://hotcopper.com.au/threads/ann-chairmans-letter-to-sharehol...

https://hotcopper.com.au/threads/an...olders.3869075/?post_id=29169848#.Wk1uo00Uln0

From letter to shareholders:

The following points highlight our current position of strength:
 We have a strong financial position with $26 million in cash and
a further $6 million soon anticipated from the R&D tax incentive
programme
 Our cash resources can fund our planned clinical activities into
2019, including new studies in Head & Neck cancer, Colorectal​

cancer and Uveal melanoma

This makes me hope it is a great deal!

Good luck all